Logo | Name | Σ | ||
---|---|---|---|---|
BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: Biotechnology French Cluster Public business cluster | 401 | 155 | 308 | |
Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: Biotechnology Pharmaceutical | 1562 | 1422 | 60 | |
Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1757 | 1562 | 123 | |
Impact Hub Join our global network of 120+ Impact Hubs accelerating inclusive and sustainable innovation at scale. What we do Our world is facing complex challenges. Challenges that will only be tackled through collaboration. At Impact Hub, we make collaboration happen by designing impactful solutions, building business for good and (re)imagining the future. Who we are We are a global network made up of 120+ Impact Hubs worldwide with 25,000+ people driving change in 60+ countries across 5 continents. Our community is a colourful bunch of impact-driven entrepreneurs, creators, innovators and intrapreneurs who are all taking action to create a better tomorrow … Sectors: Startup accelerator & VC | 5022 | 2149 | 2399 |